HDL-apoAI and its isoproteins kinetics in rabbits and gene expressin of apoAI.
HDL-apoAI and its isoproteins kinetics in rabbits and gene expressin of apoAI.
批准号:
02671114
负责人:
SAKU Keijiro
金额:
$1.02万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The metabolic turnover of HDL-apolipoproteins has been studied in human, and such studies have led to a better understanding of the mechanism of low and high plasma HDL levels. We attempted here to determine the kinetic parameters (turnover) of HDL apo AI in V, WHHL rabbits, normal Japanese white (control) rabbits, with or without cholesterol, probucol feeding. ^<125>I-labeled HDL was injected intravenously and blood samples were taken periodically for 6 days. Kinetic parameters were calculated from the apo AI specific radioactivity decay curves. We found that 1) the deficiency of plasma HDL-apo AI in the WHHL rabbits resulted from an increase in FCR and a decrease in apo AI synthesis, 2) apo AI FCR of the rabbits fed cholesterol was significantly increased but there were no change in synthetic rate, and 3) the decreased HDL or apo AI seen with probucol was apparently the result of an increase in FCR and a decrease in synthesis of HDL-apo AI, compared to findings in normal chow fed rab … More bits. A decreased synthesis of apo AI remained evident even 1 month after discontinuing probucol. The action of probucol on the intracellular synthetic process of apo AI was revealed by the reduced synthesis of proapo AI.Total RNA was isolated from rabbit intestine under various conditions as stated above, ^<32>P-labeled human apo AI cDNA probe was hybridized to RNA and specific hybridization was visualized by autoradiography. Compared to findings in normal rabbits, the WHHL had 2-3 fold lower levels of intestinal apo AI mRNA, but probucol treated rabbits showed no changes in mRNA level of apo AI. Probucol may affect the extracellular, post-translational process of apo AI, thus decreasing the levels of apo AI.In vivo conversion of recombinant human proapoplipoprotein AI (rh-Met-proapo AI) from E. coli to apolipoprotein (apo) AI was also investigated in rabbits in vivo. It was found that the radioactivity of rh-Met-proapo AI migrated to more acidic isoproteins, the conversion was complete within 24 hours. Thus, 1) the proteolytic cleavage of proapo AI is an extracellular event, 2) the converting enzyme from rabbits is functional for human proapo AI processing, and 3) the injection of rh-Met-proapo AI into rabbits facilitates understanding of the early events of HDL biogenesis in rabbits. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
朔 啓二郎他: "COMMON DISEASE SERIES 19,高脂血症(共著)" 南江堂, 264 (1991)
Keijiro Saku 等:“常见疾病系列 19,高脂血症(合著者)” Nankodo,264 (1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saku,K.,et al: "In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-Proapo AI)to apolipoprotein AI in rabbits." Biochimica et Biophysica Acta.
Saku,K.,et al:“重组人载脂蛋白原 AI (rh-Met-Proapo AI) 在兔子体内转化为载脂蛋白 AI。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saku, K., et al: "In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-Proapo AI) to apolipoprotein AI in rabbits." Biochimica et Biophysica Acta.
Saku, K. 等人:“重组人载脂蛋白原 AI (rh-Met-Proapo AI) 在兔子体内体内转化为载脂蛋白 AI。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ying,H.,Saku,K.,et al: "Putative mechanisms of action of probucol on high denssity lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits." Biochimica et Biophysica Acta. 1047. 247-254 (1990)
Ying,H.,Saku,K.,et al:“普罗布考对兔子高密度脂蛋白载脂蛋白 A-I 及其同种蛋白动力学的推定作用机制。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saku,K.,Fujuno,M.,Yamamot,K.,et al: "Cardiac function of WHHL rabbit,an animal model of familial hypercholesterolemia." Artery. 17. 271-280 (1990)
Saku,K.、Fujuno,M.、Yamamot,K.等人:“WHHL 兔的心脏功能,家族性高胆固醇血症动物模型。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
New diagnostic and therapeutic strategies for atherosclerosis using newly developed apolipoprotein A-I mimetic peptide
-
批准号:24591123
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2012
-
负责人:SAKU Keijiro
-
依托单位:
Possibility of drug discovery : Development of new peptide type of reconstituted HDL
-
批准号:21590960
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:SAKU Keijiro
-
依托单位:
Advanced medical technology on cardiovascular disease- Elucidation of the molecular mechanism and the application on various pathological conditions for the establishment of HDL therapy
-
批准号:18590826
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2006
-
负责人:SAKU Keijiro
-
依托单位:
Therapeutic strategy for atherosclerosis targeting for CETP
-
批准号:12670712
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:SAKU Keijiro
-
依托单位:
Quality, function and genetic assessments of NO, ACE and HDL in patients with coronary artery disease
-
批准号:09670773
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:SAKU Keijiro
-
依托单位:
Quantity, function and genetics of HDL as an indicator of CHD.
-
批准号:07670827
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:SAKU Keijiro
-
依托单位:
HDL-apoAI gene expression and its kinetics in vivo
-
批准号:04671503
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:1992
-
负责人:SAKU Keijiro
-
依托单位:
海外基金